当前位置: 首页 > 期刊 > 《中国实用医药》 > 2011年第8期 > 正文
编号:12097960
FOLFIRI方案一线治疗晚期大肠癌近期疗效和毒副反应的观察(2)
http://www.100md.com 2011年3月15日 林海燕 谢瑞祥
第1页

    参见附件(3139KB,3页)。

     参 考 文 献

    [1] Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal:systematic review and meta-analysis.BMJ,2000,321(7260):531.

    [2] De Gramont A,Bosset JF,Milan C, et al. Randomized trial comparing monthly low-dose leucovorinand fluoroueacil boluvorin bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuousinfusion for advanced colorectal cancer:a French intergroup study. J Clin Oncol,1997,15(2):808.

    [3] Xiao Xiaowei. Value of selective chemoembolization in treatment of hepatic metastases in colorectal carcin.WJG,1998,4(2):38-41.

    [4] KawatoY,Annuma M,Hirota Y,et al. Intracellular roles of SN-38,a metabolite of the camptothecin derivated CPT-11,in the antitumour effect of CPT-11.Cancer Res,1991,51(16):4187-4191.

    [5] Cunningham D,Pythonen S,James RD,et al. Randomised trial of irinotecan plus supportlve care versus supportlve care alone after fluorouracil failure for patients with metastati colorectal cancer.Lancet,1998,352(9138):1413-1418.

    [6] Douillard JY, Cunningham D, Roth AD, et al. Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer:a multicentre randomised trial. Lancet,2000,355(9209):1041-1047.

    [7] Lee MA, Byun JH, Shim BY, et al. Irinotecan, continuous 5-fluorouracil, and low dose of leucovorin (modified FOLFIRI) as first line of therapy in recurrent or metastatic colorectal cancer. Korean J Intern Med, 2005, 20(3):205-209.

    [8] Rothenberg ML,Meropol NJ,Poplin EA,et al. Mortality associated with irinotecan plus bolus Fluorouracil/Leucovorin:summary findings of an independent panel. J Clin Oncol, 2001,19 (18):3801-3807.

    [9] Ando Y, Saka H, Ando M, et al. Polymorphisms of UDP-Glucuronosyltransferase gene and irinotecan toxicity:a pharmacogenetic analysis. Cancer Res, 2000, 60(24):6921-6926.

    [10]Yalcin S, Oksuzoglu B, ülten Tekuzman G, et al. Biweekly irinotecan plus bolus 5-Fluorouracil and folinic acid in patients with advanced stage colorectal cancer. Jpn J Clin Oncol,2003,33(11):580-583.

    注:本文中所涉及到的图表、注解、公式等内容请以PDF格式阅读原文

您现在查看是摘要介绍页,详见PDF附件(3139KB,3页)